Showing 25 of 808 items meeting your criteria.
| | Type | Category | Supplier | |
|---|
| |
 | The ISOkine product line features highly purified, endotoxin-free recombinant Growth Factors and Cytokines developed specifically for stem cell and cell-based therapies research, regenerative medicine, and organoid production. These products are free of animal and human components, antibiotics, and contaminants such as bacterial endotoxins, viruses, and prions. |
Documents | Recombinant Proteins | ORF Genetics
| |
 | TransFix® is a stabilisation reagent that preserves cellular surface antigens and prevents cellular degradation in a variety of specimen types for flow cytometric analysis. |
Documents | Flow Cytometry | Caltag | |
 | Preserve Cerebrospinal Fluid Leukocytes for 72 hrs to Increase Disease Detection with TransFix CSF Sample Storage Tubes |
Documents | Flow Cytometry | Caltag | |
 | Leadgene provides high performance, stable and versatile enzymes to empower metabolic research across industries. |
Documents | Enzymes | LeadGene Biomedical | |
 | Abnova provides a range of products for immunotherapy. |
Documents | Immunology | Abnova Corporation | |
 | In vivo functional grade antibodies are highly purified antibodies specifically formulated for use in live animal studies. Unlike research-grade antibodies, which may contain preservatives, stabilizers, or other additives, in vivo functional grade antibodies are optimized for biological activity and safety within living organisms. These antibodies are commonly used in preclinical research to deplete immune cells, block receptor-ligand interactions, or activate specific signaling pathways. |
Documents | Antibodies | Abnova Corporation | |
 | Abnova provides RNAutomation™ mRNA Upgrades for Opentrons Flex customers with existing instruments to setup a new mRNA workstation. In addition to Opentrons distinct thermocycler, temperature, shaker-heater, magnetic block, and liquid handling modules, Abnovas newly designed vacuum manifold module allows cellulose purification to remove dsRNA impurities from the mRNA product. The preprogrammed software provides liquid handling and robotic commands for mRNA in vitro transcription, capping, oligo dT and cellulose purification. |
Documents | RNA | Abnova Corporation | |
 | Abnovas miR-191 circRNA Sponge is a synthetic circular RNA carrying multiple miR-191 response elements to competitively sequester the miRNA and block its binding to endogenous mRNAs. Lacking a 5′cap and 3′ poly(A) tail, the circular RNA resists exonucleolytic degradation, resulting in higher intracellular levels and robust derepression of targets. |
Documents | RNA | Abnova Corporation | |
 | Discover AMDs diagnostic assays for STDs, genetic biomarkers, respiratory panels, infectious diseases, cancer biomarkers, animal health and food safety. |
Documents | PCR Kits | Advanced Molecular Diagnostics (AMD) | |
 | Cureline provides a comprehensive range of HIPAA-GDPR/IRB-compliant biobanking and laboratory services for biomedical research and product development clients. |
Documents | Supplier Introduction | Cureline | |
 | With their ability to activate, neutralize or block the activity of their antigen, these antibodies are powerful tools for elucidating the function of a specific protein as well as interrogating the physiological impact of disrupting the proteins normal function. Leinco antibodies are suitable for numerous areas of research. |
Documents | Antibodies | Leinco Technologies | |
 | Research-grade active and FC-mutedTM biosimilars with best-in-class quality. |
Documents | Antibodies (Biosimilars) | Leinco Technologies | |
 | Research-grade biosimilars have been developed as reagents to avoid the necessity of sourcing expensive therapeutic antibodies that are only available in large quantities. These non-therapeutic, recombinantly-expressed antibodies have the same variable region sequence as the corresponding therapeutic antibody, together with a human IgG constant region. |
Documents | Citations | Leinco Technologies | |
 | Study using Influenza A IgG antibodies from Leinco Technologies, Inc. |
Documents | Citations | Leinco Technologies | |
 | This case study compares PD-1, PD-L1 and CTLA4 antibodies from Leinco Technologies vs a competitors products in a series of in vivo mouse experiments. The objective of the study was to evaluate the in vivo efficacy of the various clones on tumor growth and tolerability. |
Documents | Citations | Leinco Technologies | |
 | In this study, three antibody clones available from Leinco Technologies (Table 1) were tested for their ability to bind and visualize mpox virus in cell cultures. The work was
performed in the lab of Dr. John Connor <http://www.connorlab.com/>, which focuses on understanding how the virus-host interaction works and methods to tip the balance in favor of the host. To do this they aim to determine how viruses hijack infected cells, and how cells defend themselves against viral infection. |
Documents | Citations | Leinco Technologies | |
 | Leinco Technologies understands the need for reliable, high-performance IVD critical raw materials such as antibodies, proteins, and buffers. Our infectious disease antibodies and proteins catalog includes confirmed matched pairs for ELISA and Lateral Flow applications as well as cutting-edge recombinant antibodies with high specificity and sensitivity. We also offer recombinant antigens and blocking peptides to advance your infectious disease research. |
Documents | Immunology | Leinco Technologies | |
 | Lot-to-lot reproducible monoclonal antibodies against mouse cell-specific proteins and cytokines are paramount for reproducible results. Depletion can occur naturally or be induced for treatment purposes. Therefore, it is a useful tool in therapeutic, immunotherapy and diagnostic research. It is common practice for researchers to use antibodies to remove a specific cell type to infer its function and mouse cell depletion in vivo experiments are used to establish the role of specific cell types in a variety of immunological processes. Many of these antibodies have been developed by academic and government labs all over the world and have been reported and referenced for use in in vivo studies to deplete a specific cell type. |
Documents | Immunology | Leinco Technologies | |
 | mAbMods™ recombinant antibodies have been engineered to have identical antigen binding variable domains to those of the traditional clones from which they are derived, but the IgG constant regions have been engineered to be of mouse origin. This reduces immunogenic responses in the mouse which can lead to adverse immunological reactions and gradual loss of activity. |
Documents | Antibodies | Leinco Technologies | |
 | Consistent and reliable antibodies targeting mouse immune checkpoints and related proteins are essential for advancing cancer research. Achieving lot-to-lot reproducibility is crucial for maintaining the integrity of scientific studies. Leinco Technologies offers a range of functional grade antibodies and is known for our exceptional lot-to-lot reproducibility, minimal endotoxin levels, and absence of detectable impurities. With these high-quality antibodies, researchers can confidently conduct in vivo studies to further our understanding of cancer immunotherapy. |
Documents | Cancer | Leinco Technologies | |
 | Leinco Technologies offers high-purity research-grade biosimilar antibodies with the same specifications as many therapeutic antibodies. Therapeutic antibodies are widely used for the treatment of diseases, including cancer and autoimmunity. |
Documents | Antibodies (Biosimilars) | Leinco Technologies | |
 | In vivo grade antibodies have a variety of uses in biological research, from discovery of cell signaling pathways to manipulation of biological systems in animal models for pre-clinical studies. In vivo functional grade antibodies from Leinco Technologies have the highest purity standards in the industry, with low endotoxin levels, and screening to ensure low aggregates. These antibodies are produced in our cGMP and ISO 9001:2015 / ISO 13485:2016 certified facility and are available in custom concentrations and package sizes. |
Documents | Antibodies | Leinco Technologies | |
 | 3Helixs Collagen Hybridising Peptide (CHP) is a synthetic peptide that can specifically bind to denatured collagen by structural recognition of exposed alpha-strands. Their in vivo
CHP is conjugated to a near-infrared dye to enable accurate and reliable measurements of collagen turnover in live animal models. |
Documents | Peptides | 3Helix | |
 | CHPs are unique collagen-targeting peptides that only bind to denatured collagen. 3Helixs Collagen Hybridising Peptide is a synthetic peptide that can specifically bind to denatured collagen through hydrogen bonding. |
Documents | Peptides | 3Helix | |
 | Whitepaper by Dr. Lucas Bennink and Dr. Yang Li 3Helix Inc. Salt Lake City, Utah, USA. 84108 |
Documents | Peptides | 3Helix | |